C4 Therapeutics, Inc. (CCCC) Net income 2019–2025
C4 Therapeutics, Inc. (CCCC) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$105.0MFY2025 · since FY2019: -$34.1M → -$105.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$105.0M | +0.3% |
| FY2024 | -$105.3M | +20.5% |
| FY2023 | -$132.5M | -3.4% |
| FY2022 | -$128.2M | -52.8% |
| FY2021 | -$83.9M | -26.5% |
| FY2020 | -$66.3M | -94.5% |
| FY2019 | -$34.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice